2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

Diethylstilbestrol (DES) was prescribed to pregnant women from 1940 to the 1970s to prevent miscarriage, premature labour and pregnancy complications.

The prescription discount card promised by Gov. Katie Hobbs is now available. It will be up to Arizonans to decide whether it ...

Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and ...

Dr. Mehmet Oz and Dr. Marty Makary touted that reducing steps for biosimilar approval will lower costs by increasing competition.

From prescription medications that promise life-changing results to vitamin supplements that promote natural wellness, the options are endless — and so are the risks.

Walter: On average, people go to rehab multiple times before they enter recovery. Someone who attends a 30-day program and ...

Dr. George Tidmarsh, the head of the Food and Drug Administration’s drug center, abruptly resigned Sunday amid concerns about ...

Developers of biosimilars, medicines that are near-identical copies of biologic drugs, will no longer be required to conduct clinical trials to prove effectiveness.

Last year, these treatments accounted for 75% of the $236B in annual sales set to vanish with the loss of exclusivity.

The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.